From SIMPLER cohorts, Eurofins Genomics successfully extracted 38.000 samples and run 40.500 samples on GWAS microarray during a one-year period.
The work on producing genotype data for the population-based longitudinal cohorts in SIMPLER, a Swedish national research infrastructure hosted by Uppsala University, has been finalised and the project coordinator in SIMPLER describes the collaboration with Eurofins Genomics as very successful.
“We are very happy with Eurofins’ competence and professional approach” comments Anna-Karin Kolseth, project coordinator, SIMPLER.
The infrastructure SIMPLER consists of questionnaire data and biological samples for research on how dietary, lifestyle factors and genetics affect health, especially during the latter part of life. The work conducted by Eurofins Genomics under this project has been the DNA extraction of 38.000 saliva and blood samples, and then genotyping on microarrays, this included additional DNA samples from the SIMPLER biobank resulting in a total of 40.500 samples being genotyped. The success rate (sample to genotype) has been extremely high, above 99%. The project began in late spring 2019 and was completed on time as scheduled at the end of 2020. Genotyping was performed on the Illumina Infinium Global Screening Array (GSA MD 3.0).
SIMPLER have data extending 30 years back in time and the cohorts have been repeatedly assessed over time. Research on data from SIMPLER has and will continue to contribute insights and recommendations on diet and lifestyle choices. The additional use of molecular methods for exploring the cohorts will enhance and enable the development of new biomarkers for easier and more accurate diagnosis of chronic diseases and their precursors and to develop new individualised treatments. For more detailed information please visit www.simpler4health.se
Eurofins Genomics is the leading provider of genomics services in Europe and runs one of the largest commercial array facilities, utilising both Illumina and ThermoFisher Scientific (formally Affymetrix) technologies. As part of its portfolio, Eurofins Genomics also offers Next Generation Sequencing (NGS), Sanger Sequencing, oligos and microarray services. Customers benefit from product innovation developed by a dedicated R&D team and receive detailed support and analysis from the Eurofins Genomics bioinformatics department. Eurofins Genomics assists a significant variety of clients from academia to pharma. For more information please visit www.eurofinsgenomics.com
Please contact Anna-Karin Kolseth (project coordinator, simpler@surgsci.uu.se, +46 72 9999 241) for further reference on the project.
Please contact Jeppe Skytte (Project Sales Manager – Nordics, JeppeSkytte@eurofins.com, +45 2284 2656) for questions to Eurofins Genomics services. Or your local sales representative.